Komori
K Pharma (4896) · RiskRestated

Uncertainty in the Business Environment Due to Geopolitical Tensions and Economic Downturns at Home and Abroad

First written in FY2023-Q3. 5 of 7 entries say "Restated". Latest entry: FY2026-H1.

7entries
4years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2023-Q3RestatedFY2024-Q1 – FY2026-H12023: 120232024: 320242025: 120252026: 22026
Same theme, other companies

The whole theme swung hardest in 2025: 45 of 80 companies on the "Worse" side.

50 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 141 companies compared. The sentences above are computed from all 141.
Full recordFilings, disclosures and news, newest first
  1. FY2026-H1RestatedAnnual report

    「During the current interim accounting period, the Japanese economy remained firm, with a gradual increase in capital investment and improvements in employment and income conditions. However, the outlook remains uncertain due to constraints on supplies of materials resulting from the situation in the Middle East and persistently high energy prices.」

    The company continues the theme of uncertainty in the business environment, citing constraints on material supplies due to the Middle East situation and persistently high energy prices.
  2. FY2025RestatedAnnual report

    「The outlook remains uncertain due to U.S. tariff policy and continued instability in international conditions.」

    The company identifies U.S. tariff policy, in addition to unstable international conditions, as a source of uncertainty.
  3. FY2024RestatedAnnual report

    「Against a backdrop of continuing geopolitical risks in Russia and Ukraine, the Middle East, China and Taiwan, changes in global conditions including future U.S. policy, unstable foreign exchange markets, higher resource and raw-material prices, rising inflation, increasing risks of economic slowdown from global monetary tightening and concerns over a slowdown in China, the Noto Peninsula Earthquake occurred in January 2024. The outlook therefore remains uncertain.」

    The company continues to cite geopolitical risks, foreign exchange markets, resource and raw-material prices, inflation, monetary tightening, China's economic slowdown and the Noto Peninsula Earthquake, as well as changes in U.S. policy, as sources of uncertainty.
  4. FY2024-H1RestatedAnnual report

    「Against a backdrop of continuing geopolitical risks in Russia and Ukraine, the Middle East, China and Taiwan, unstable foreign exchange markets, higher resource and raw-material prices, rising inflation, increasing risks of economic slowdown from the effects of global monetary tightening and concerns over a slowdown in China, the Noto Peninsula Earthquake occurred in January 2024. The outlook therefore remains uncertain.」

    The company continues to cite geopolitical risks, foreign exchange markets, resource and raw-material prices, inflation, monetary tightening, China's economic slowdown and the Noto Peninsula Earthquake as sources of uncertainty.
  5. FY2024-Q1RestatedAnnual report

    「Against a backdrop of continuing geopolitical risks in Russia and Ukraine, the Middle East, China and Taiwan, unstable foreign exchange markets, higher resource and raw-material prices, rising inflation and concerns over a slowdown in the Chinese economy, the Noto Peninsula Earthquake occurred in January 2024. The outlook therefore remains uncertain.」

    The company continues to list geopolitical risks, foreign exchange markets, resource and raw-material prices, inflation and concerns over China's slowdown, adding the Noto Peninsula Earthquake in January 2024.
  6. FY2023WorsenedAnnual report

    「In addition to the protracted Russia-Ukraine conflict, geopolitical risks have emerged in the Middle East, China and Taiwan, while energy prices remain high, economic slowdown is expected as countries tighten monetary policy, foreign exchange markets remain unstable and concerns persist over a slowdown in the Chinese economy. The outlook therefore remains uncertain.」

    In addition to existing geopolitical tensions, the company lists energy prices, monetary tightening, foreign exchange markets and the Chinese economic slowdown as sources of uncertainty.
  7. FY2023-Q3First statedAnnual report

    「Numerous risks could weigh on the Japanese economy, including the prolonged Russian invasion of Ukraine, concerns over economic downturns in Europe, the United States and China, and geopolitical risks in the Middle East and East Asia. The outlook therefore remains extremely uncertain.」

    The company lists the Russian invasion of Ukraine, concerns over economic downturns in Europe, the United States and China, and geopolitical risks in the Middle East and East Asia.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for K Pharma yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Uncertainty in the Business Environment Due to Geopolitical Tensions and Economic Downturns at Home and Abroad | K Pharma,Inc. (4896) | Komori